August 19th, 2009
On November 24, 2008, researchers in the United States stated that older diabetics taking GlaxoSmithKline's Avandia to control their blood sugar had a higher risk of death and heart failure while on the drug than those who took Takeda Pharmaceutical's Actos, a drug in the same class. Researchers said the ...
August 10th, 2009
A November 20, 2008, Philadelphia Inquirer article discusses how a Maryland doctor said she felt "threatened and disappointed" after GlaxoSmithKline P.L.C. urged her to stop discussing her concerns that the company's diabetes drug, Avandia, caused heart problems.
The doctor’s claim marks the second time that GlaxoSmithKline has been accused of trying ...
June 5th, 2009
On October 30, 2008, the consumer group Public Citizen asked the FDA to ban GlaxoSmithKline PLC's problematic diabetes drug Avandia over safety concerns. The move follows updated practice guidelines released last week by the American Diabetes Association and the European Association for the Study of Diabetes that recommend doctors not ...
June 3rd, 2009
On July 2, 2008 an FDA panel suggested that diabetes drugs should face stricter standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended. FDA advisers voted 14-2 on July 2, 2008 that all new diabetes drugs must undergo longer studies to ...
May 22nd, 2009
The FDA recently announced that the agency is primed to finalize long-awaited sunscreen label changes designed to give consumers a better idea of the sun protection they’re getting.
Companies that make sunscreens will now be required to provide information on the amount of ultraviolet A (UVA) screening provided by their products. ...
May 21st, 2009
New information has been released linking both Avandia and Fosamax, to adverse events. One study found that long-term use of Avandia increases risk for bone fractures. Additionally, a second study illustrates that Fosamax, which is used to prevent fractures in women with osteoporosis, may be associated with a higher risk ...
May 1st, 2009
On April 8, 2008, the FDA publicized in a warning to GlaxoSmithKline that the company was unsuccessful in reporting all of the required post-approval data on its widely prescribed diabetes drug Avandia. A strong warning about heart attack risk was added to the label of Avandia in November 2007, and ...
April 14th, 2009
GlaxoSmithKline faces yet another legal battle, after an Oklahoma man filed a lawsuit claiming Avandia, a popular diabetes medication caused him to experience heart problems that required bypass surgery. The plaintiff alleges in the lawsuit that GlaxoSmithKline should have known that Avandia was linked with a substantial increased danger of ...
December 18th, 2008
The National Institute of Health was forced to shut down a portion of a major study on heart disease and diabetes after an unforeseen number of deaths amongst patients receiving intense therapy to decrease their blood sugar.
The therapy was aimed at reducing to normal levels the blood sugar of type ...
December 10th, 2008
European regulators recommended that patients with heart disease or leg pains, a possible sign of heart problems should not take GlaxoSmithKline's diabetes drug Avandia.
The European Medicines Agency also said in its decision to update Avandia's label that the drug must not be used by people having a heart attack or ...
